CHIESI USA, INC. et al v. GLAND PHARMA LTD. > Summary
Court Case Number 2:19-cv-18565
Filing Date Sep 30, 2019
Termination Date Jun 29, 2022
Court New Jersey District Court
Status Judgment - Judgment on Consent
Defendant
Plaintiff Attorneys
16Chiesi USA, Inc.
Attorney Name: Robert C. Brady
Gibbons P.C.
Chiesi USA, Inc.
Attorney Name: Charles H. Chevalier
Gibbons P.C.
Chiesi USA, Inc.
Attorney Name: Christine A. Gaddis
Gibbons P.C.
Chiesi Farmaceutici
Attorney Name: Robert C. Brady
Gibbons P.C.
Chiesi Farmaceutici
Attorney Name: Charles H. Chevalier
Gibbons P.C.
Chiesi Farmaceutici
Attorney Name: Christine A. Gaddis
Gibbons P.C.
Chiesi Farmaceutici
Attorney Name: Edgar H. Haug
Haug Partners
Chiesi Farmaceutici
Attorney Name: Angus Chen
Haug Partners
Chiesi Farmaceutici
Attorney Name: Elizabeth J. Murphy
Haug Partners
Chiesi USA, Inc.
Attorney Name: Edgar H. Haug
Haug Partners
Chiesi USA, Inc.
Attorney Name: Angus Chen
Haug Partners
Chiesi USA, Inc.
Attorney Name: Elizabeth J. Murphy
Haug Partners
Chiesi USA, Inc.
Attorney Name: Andrew S. Roper
Haug Partners
Chiesi USA, Inc.
Attorney Name: Anna N. Lukacher
Haug Partners
Chiesi Farmaceutici
Attorney Name: Hailey S. Verano
Quinn Emanuel Urquhart & Sullivan
Chiesi Farmaceutici
Attorney Name: Geoffrey A. Kirsner
Quinn Emanuel Urquhart & Sullivan
Defendant Attorneys
5Gland Pharma Limited
Attorney Name: Justin T. Quinn
Robinson Miller
Gland Pharma Limited
Attorney Name: Helen H. Ji
ArentFox Schiff
Gland Pharma Limited
Attorney Name: John K. Hsu
ArentFox Schiff
Gland Pharma Limited
Attorney Name: Imron T. Aly
ArentFox Schiff
Gland Pharma Limited
Attorney Name: Arun J. Mohan
Latham & Watkins
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10039780 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Aug 7, 2018 |
| 09700575 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Jul 11, 2017 |
| 09439921 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Sep 13, 2016 |
| 09427448 | Methods of treating, reducing the incidence of, and/or preventing ischemic events | Aug 30, 2016 |
| 09295687 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Mar 29, 2016 |
| 08680502 | Amorphous semiconductor layer memory device | Mar 25, 2014 |
| 06130208 | Formulation containing a nucleotide analogue | Oct 10, 2000 |
